How it went
Did it last?
- No one said the benefit wore off.
- No one said they needed to keep it up to stay well.
Read from what people wrote. A story that ends without a follow-up counts as lasting, so treat these as minimums.
| Outcome described | Accounts | Share |
|---|---|---|
| Full recovery | 0 | 0% |
| Near-full | 0 | 0% |
| Substantial | 0 | 0% |
| Partial | 1 | 33% |
| Relapsed | 0 | 0% |
| No benefit | 2 | 67% |
Only 3 accounts. Treat these percentages as anecdotes, not rates.
Who published these accounts
Right-hand number: share describing a full or near-full recovery. Pages that sell something, and advocacy sites, tend to publish only the successes.
All 3 accounts
-
Amantadine - A Fatigue Reducer for Long COVID and ME/CFS?
Amantadine, tried in 2003 at an unspecified dose for her ME/CFS. Her illness duration and severity beforehand are not stated in her comment. She reports it "never helped and did nothing for me," describing no improvement in fatigue or other symptoms. She…
-
Amantadine - A Fatigue Reducer for Long COVID and ME/CFS?
Amantadine, tried at an unspecified dose about a year into her ME/CFS. No further detail on total illness duration or severity is given in her comment. She reports it "was no help at all" for her fatigue or other core symptoms. She adds that it actively…
-
Beginning of improvement?
Six weeks into a self-directed antiviral/immune-booster stack (famciclovir, amantadine, cimetidine, astragalus, inosine, vitamin C) for CFS that began after an unresolved flu six years earlier, reports "much more energy, no brain fog, no fatigue, no chest…